Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XBiotech Inc. Director's Dealing 2019

Mar 4, 2019

34229_dirs_2019-03-04_f9b3840e-6936-42af-b731-24b91a4c6488.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2018-12-24

Reporting Person: MCKENZIE W THORPE (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-12-24 Common Stock P 24838 $5.882 Acquired 27738 Indirect
2018-12-26 Common Stock P 18636 $5.0744 Acquired 46374 Indirect
2018-12-27 Common Stock P 1364 $4.9163 Acquired 47738 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3398600 Direct
Common Stock 11500 Indirect
Common Stock 100000 Indirect